<DOC>
	<DOC>NCT01627288</DOC>
	<brief_summary>The purpose of this study is to determine the maximum tolerated dose of integrated boost radiation therapy when given with concurrent chemotherapy (cisplatin).</brief_summary>
	<brief_title>Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Biopsy confirmed malignancy of the gynecologic tract Involved pelvic or paraaortic lymph nodes Treatment plan to include delivery of concurrent chemoradiotherapy. Good performance status Negative pregnancy test in women of childbearing potential Signed studyspecific informed consent Lab results within study specific limits Prior radiation to the abdomen or pelvis A history of Scleroderma or Inflammatory bowel disease Contraindication to chemotherapy or radiation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>